News

Mark Huffman, MD, MPH, William Bowen Endowed Professor of Medicine in the Cardiovascular Division and Co-Director of the WashU Global Health Center, will be a featured presenter at the South Asia Forum for Clinical Development in Colombo, Sri Lanka. This year will be the fourth for the SAF, and programming will focus on non-communicable cardiovascular, […]

The Academy of Educators at WashU Medicine is an institutional collaboration dedicated to fostering a culture of educational excellence and an institutionally valued community of leaders in health science education.

Zainab Mahmoud, M.D., M.Sc., an assistant professor of medicine at Washington University School of Medicine in St. Louis will receive the inaugural Jack Sarver Prize in Clinical Science and Jack Sarver Prize in Basic Science, respectively, at the American Heart Association’ Scientific Sessions 2025. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The awards will be presented during dinner events of the Council on Clinical Cardiology and the Council on Basic Cardiovascular Sciences on Saturday, November 8, 2025.

A new paper in JACC: Advances delves into the factors that may affect implementation of a polypill for heart failure with reduced ejection fraction (HFrEF)—assuming one proves safe and effective—and outlines strategies for an eventual rollout. This exercise “just reinforces the idea, in addition to previous data showing therapeutic inertia and reluctance to use other single-pill combination therapies for cardiovascular diseases, that we need to plan in advance. We need to be strategic in how we design the heart failure polypill and how we implement it, and what strategies and what messages we provide with that,” said Justin Chen, MD (WashU Medicine, St. Louis, MO), one of the lead authors.